Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulipristal acetate plus misoprostol for induced abortion through 63 days of pregnancy
ISRCTN35625202Phase 2Completed
- Sponsor
- Gynuity Health Projects
- Start
- Aug 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ulipristal and misoprostol in pregnancy (3 arms), sponsored by Gynuity Health Projects. Primary endpoint: Adverse events. Started Aug 2022; status: completed.
02
Drugs
ulipristalmisoprostol
03
Conditions
pregnancy
Beyond the preview
Go deeper on ISRCTN35625202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN35625202.